De Caterina R - Search Results

1

Contemporary use of glycoprotein IIb/IIIa inhibitors.

Kristensen SD, Würtz M, Grove EL, De Caterina R, Huber K, Moliterno DJ, Neumann FJ. Kristensen SD, et al. Among authors: de caterina r. Thromb Haemost. 2012 Feb;107(2):215-24. doi: 10.1160/TH11-07-0468. Epub 2012 Jan 11. Thromb Haemost. 2012. PMID: 22234385 Review.

2

n-3 polyunsaturated fatty acids: update 1995.

Endres S, De Caterina R, Schmidt EB, Kristensen SD. Endres S, et al. Among authors: de caterina r. Eur J Clin Invest. 1995 Sep;25(9):629-38. doi: 10.1111/j.1365-2362.1995.tb01978.x. Eur J Clin Invest. 1995. PMID: 7498235 Review.

3

n-3 fatty acids and renal diseases.

De Caterina R, Endres S, Kristensen SD, Schmidt EB. De Caterina R, et al. Am J Kidney Dis. 1994 Sep;24(3):397-415. doi: 10.1016/s0272-6386(12)80896-1. Am J Kidney Dis. 1994. PMID: 8079965 Review.

4

Fish oil and ischaemic heart disease.

Kristensen SD, De Caterina R, Schmidt EB, Endres S. Kristensen SD, et al. Among authors: de caterina r. Br Heart J. 1993 Sep;70(3):212-4. doi: 10.1136/hrt.70.3.212. Br Heart J. 1993. PMID: 8398488 Free PMC article. Review. No abstract available.

5

Glycoprotein IIb-IIIa antagonists in non-ST elevation acute coronary syndromes and percutaneous interventions: from pharmacology to individual patient's therapy: part 1: the evidence of benefit.

Zimarino M, De Caterina R. Zimarino M, et al. Among authors: de caterina r. J Cardiovasc Pharmacol. 2004 Mar;43(3):325-32. doi: 10.1097/00005344-200403000-00001. J Cardiovasc Pharmacol. 2004. PMID: 15076214 Review.

6

Glycoprotein IIb-IIIa antagonists in non-ST elevation acute coronary syndromes and percutaneous interventions: from pharmacology to individual patient's therapy: Part 2: When and how to use various agents.

Zimarino M, De Caterina R. Zimarino M, et al. Among authors: de caterina r. J Cardiovasc Pharmacol. 2004 Apr;43(4):477-84. doi: 10.1097/00005344-200404000-00001. J Cardiovasc Pharmacol. 2004. PMID: 15085057 Review.

7

Marine n-3 polyunsaturated fatty acids and coronary heart disease. Part I. Background, epidemiology, animal data, effects on risk factors and safety.

Schmidt EB, Arnesen H, de Caterina R, Rasmussen LH, Kristensen SD. Schmidt EB, et al. Among authors: de caterina r. Thromb Res. 2005;115(3):163-70. doi: 10.1016/j.thromres.2004.09.006. Thromb Res. 2005. PMID: 15617737 Review.

8

Marine n-3 polyunsaturated fatty acids and coronary heart disease: Part II. clinical trials and recommendations.

Schmidt EB, Arnesen H, Christensen JH, Rasmussen LH, Kristensen SD, De Caterina R. Schmidt EB, et al. Among authors: de caterina r. Thromb Res. 2005;115(4):257-62. doi: 10.1016/j.thromres.2004.09.007. Thromb Res. 2005. PMID: 15668184 Review. No abstract available.

9

Emergency coronary artery bypass grafting in patients with acute myocardial infarction treated with glycoprotein IIb/IIIa receptor inhibitors.

De Carlo M, Maselli D, Cortese B, Ciabatti N, Gistri R, Levantino M, Balbarini A, De Caterina R, Petronio AS. De Carlo M, et al. Among authors: de caterina r. Int J Cardiol. 2008 Jan 24;123(3):229-33. doi: 10.1016/j.ijcard.2007.02.005. Epub 2007 Apr 11. Int J Cardiol. 2008. PMID: 17433463 Review.

10

New anticoagulants for atrial fibrillation.

De Caterina R, Kristensen SD, Renda G. De Caterina R, et al. J Cardiovasc Med (Hagerstown). 2009 Jun;10(6):446-53. doi: 10.2459/JCM.0b013e3283249aee. J Cardiovasc Med (Hagerstown). 2009. PMID: 19365276 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

865 results

Search Page

Filters